KR850003503A - 갱글리오사이드 및 그 유도체의 흡입투여 키트와 이에 적합한 약제 조성물 - Google Patents

갱글리오사이드 및 그 유도체의 흡입투여 키트와 이에 적합한 약제 조성물 Download PDF

Info

Publication number
KR850003503A
KR850003503A KR1019840006985A KR840006985A KR850003503A KR 850003503 A KR850003503 A KR 850003503A KR 1019840006985 A KR1019840006985 A KR 1019840006985A KR 840006985 A KR840006985 A KR 840006985A KR 850003503 A KR850003503 A KR 850003503A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
acid
kit
ganglioside
site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019840006985A
Other languages
English (en)
Korean (ko)
Inventor
델라 발레 프란세스코 (외 1)
Original Assignee
프란세스코 델라 발레
피디아 에스.피.에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프란세스코 델라 발레, 피디아 에스.피.에이 filed Critical 프란세스코 델라 발레
Publication of KR850003503A publication Critical patent/KR850003503A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1019840006985A 1983-11-08 1984-11-08 갱글리오사이드 및 그 유도체의 흡입투여 키트와 이에 적합한 약제 조성물 Ceased KR850003503A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8349288A IT1212896B (it) 1983-11-08 1983-11-08 Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
IT49288A/83 1983-11-08

Publications (1)

Publication Number Publication Date
KR850003503A true KR850003503A (ko) 1985-06-20

Family

ID=11270228

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840006985A Ceased KR850003503A (ko) 1983-11-08 1984-11-08 갱글리오사이드 및 그 유도체의 흡입투여 키트와 이에 적합한 약제 조성물

Country Status (22)

Country Link
US (1) US4639437A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0145209B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS60132920A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR850003503A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE47035T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU569920B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE900994A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH662278A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3480053D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK160129C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8608532A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2554346B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR80853B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL73292A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN163563B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1212896B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU85633A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX163574B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO844443L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ209974A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT79466B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA848541B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
JPS6368526A (ja) * 1986-09-11 1988-03-28 Mect Corp シアリルグリセライドからなる神経障害疾患治療剤
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
CA2070823C (en) * 1989-12-05 1999-01-12 William H. Ii Frey Neurologic agents for nasal administration to the brain
US6407061B1 (en) * 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
IT1249034B (it) * 1990-06-29 1995-02-11 Fidia Spa Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
WO1992017189A1 (en) * 1991-03-29 1992-10-15 The Regents Of The University Of California Gangliosides with immunosuppressive activity
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5567684A (en) * 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
US7273618B2 (en) * 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
WO2003017949A2 (en) 2001-08-29 2003-03-06 Neose Technologies, Inc. Novel synthetic ganglioside derivatives and compositions thereof
MXPA05009480A (es) 2003-03-06 2006-02-22 Neose Technologies Inc Metodos y composiciones para la sintesis enzimatica de gangliosidos.
CU23317A1 (es) 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
EP2410846B1 (en) 2009-03-25 2016-09-07 Seneb Biosciences, Inc. Glycolipids as treatment for disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL262354A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1960-03-17
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
US4094968A (en) * 1972-09-06 1978-06-13 Burroughs Wellcome Co. Treatment for allergy and method of composition thereof
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions

Also Published As

Publication number Publication date
DE3480053D1 (en) 1989-11-16
IL73292A0 (en) 1985-01-31
FR2554346A1 (fr) 1985-05-10
DK505584A (da) 1985-05-09
JPS60132920A (ja) 1985-07-16
MX163574B (es) 1992-06-02
FR2554346B1 (fr) 1987-11-20
US4639437A (en) 1987-01-27
IT1212896B (it) 1989-11-30
BE900994A (nl) 1985-05-07
NZ209974A (en) 1987-02-20
PT79466A (en) 1984-12-01
EP0145209A2 (en) 1985-06-19
DK160129C (da) 1991-07-01
EP0145209B1 (en) 1989-10-11
NO844443L (no) 1985-05-09
DK505584D0 (da) 1984-10-23
DK160129B (da) 1991-02-04
IL73292A (en) 1988-07-31
ZA848541B (en) 1985-06-26
IT8349288A0 (it) 1983-11-08
CH662278A5 (fr) 1987-09-30
EP0145209A3 (en) 1986-11-26
GR80853B (en) 1985-02-26
LU85633A1 (fr) 1985-06-04
ES8608532A1 (es) 1986-07-16
ATE47035T1 (de) 1989-10-15
AU569920B2 (en) 1988-02-25
IN163563B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-10-08
PT79466B (en) 1986-12-12
AU3518984A (en) 1985-05-16
ES537300A0 (es) 1986-07-16
JPH0211570B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-03-14

Similar Documents

Publication Publication Date Title
KR850003503A (ko) 갱글리오사이드 및 그 유도체의 흡입투여 키트와 이에 적합한 약제 조성물
ES2061858T3 (es) Derivados sustituidos en posicion 7 del acido 3,5-dihidroxihept-6-inoico, procedimiento para su preparacion, su empleo como medicamentos, asi como productos intermedios.
PT88944A (pt) Processo para a preparacao de novos derivados de benzociclohepteno e de composicoes farmaceuticas que os contem
EA199700267A1 (ru) Применение фумагиллола и его производных для приготовления антиинфекционных интестинальных препаратов и фармацевтическая композиция на их основе
IL75337A (en) Polyenoic acids omega-substituted by a 4,5-dimethoxy-2-methyl-quinone or a 4,5-dimethoxy-2-methyl-phenyl group,process for the preparation thereof and pharmaceutical compositions containing the same
AU639717B2 (en) 24-homo vitamin d derivatives, process for their production and pharmaceutical preparations obtained therefrom
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
MX6526E (es) Procedimiento para la preparacion de derivados 3-alil-7,8-dihidroxi-6-halogeno-1-(4-hidroxifenil)-2,3,4,5-tetrahidro-1h-3-benzazepina
FR2649110B1 (fr) Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BR9911274A (pt) Derivados da artemisinina, seus processos de preparação e as composições farmacêuticas que os contêm
IL57384A0 (en) Imidazole derivatives process for their preparation and pharmaceutical preparations containing them
KR880009975A (ko) 화합물
AR246745A1 (es) Procedimiento para preparar nuevos derivados de 1,4-di-desoxi-1,4-imino-d-arabinitol, sus isomeros opticos y geometricos y sus sales farmaceuticamente aceptables.
DE3675977D1 (de) Pharmazeutische zusammensetzungen zur verminderung der nebenwirkungen der anti-krebs-chemotherapie und erhoehung der immunitaet.
ES471993A1 (es) Procedimiento de preparacion de nuevos derivados de alcaloi-des pentaciclicos
DE3175733D1 (en) An orally administered drug form comprising a glycosidic antibiotic and an adjuvant
IL41868A (en) Pharmaceutical preparations containing d-penicillamine
NO126529B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB1416831A (en) Dihydroxydiphenylmethane derivatives
SE9002251L (sv) Foerfarande foer framstaellning av vattenloeslig primycin och dess komponenter samt farmaceutiska kompositioner innehaallande dessa
GB1337085A (en) Aminoalkyl bis-4-chlorophenoxy acetates and process for their preparation
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.
PT81066B (pt) Processo para a preparacao de derivados de arfamenina (acido 5-amino-8-guanidino-4-oxo-2-fenilmetil-octanoico) e de composicoes farmaceuticas que os contem
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
DK214884D0 (da) Chlorphenoxyacetatderivat

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19841108

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19860722

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19861126

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19870328

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19861126

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 19860722

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I